This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


5fi7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (06:52, 19 July 2023) (edit) (undo)
 
(One intermediate revision not shown.)
Line 1: Line 1:
==Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]oxy]pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl]ethanamide==
==Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]oxy]pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl]ethanamide==
-
<StructureSection load='5fi7' size='340' side='right' caption='[[5fi7]], [[Resolution|resolution]] 2.50&Aring;' scene=''>
+
<StructureSection load='5fi7' size='340' side='right'caption='[[5fi7]], [[Resolution|resolution]] 2.50&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5fi7]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FI7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FI7 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5fi7]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FI7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FI7 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5XZ:2-PHENYL-~{N}-[5-[(3~{S})-3-[[5-(2-PHENYLETHANOYLAMINO)-1,3,4-THIADIAZOL-2-YL]OXY]PYRROLIDIN-1-YL]-1,3,4-THIADIAZOL-2-YL]ETHANAMIDE'>5XZ</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fi2|5fi2]], [[5fi6|5fi6]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5XZ:2-PHENYL-~{N}-[5-[(3~{S})-3-[[5-(2-PHENYLETHANOYLAMINO)-1,3,4-THIADIAZOL-2-YL]OXY]PYRROLIDIN-1-YL]-1,3,4-THIADIAZOL-2-YL]ETHANAMIDE'>5XZ</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fi7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fi7 OCA], [http://pdbe.org/5fi7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fi7 RCSB], [http://www.ebi.ac.uk/pdbsum/5fi7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fi7 ProSAT]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fi7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fi7 OCA], [https://pdbe.org/5fi7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fi7 RCSB], [https://www.ebi.ac.uk/pdbsum/5fi7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fi7 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/GLSK_HUMAN GLSK_HUMAN]] Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate in the brain. Isoform 2 lacks catalytic activity.
+
[https://www.uniprot.org/uniprot/GLSK_HUMAN GLSK_HUMAN] Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate in the brain. Isoform 2 lacks catalytic activity.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 19: Line 19:
</div>
</div>
<div class="pdbe-citations 5fi7" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 5fi7" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Glutaminase 3D structures|Glutaminase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
-
[[Category: Cerione, R]]
+
[[Category: Large Structures]]
-
[[Category: Huang, Q]]
+
[[Category: Cerione R]]
-
[[Category: Complex]]
+
[[Category: Huang Q]]
-
[[Category: Glutaminase c]]
+
-
[[Category: Hydrolase-hydrolase inhibitor complex]]
+
-
[[Category: Inhibitor]]
+

Current revision

Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]oxy]pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl]ethanamide

PDB ID 5fi7

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5fi7"
Personal tools